U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076706) titled 'Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia' on July 01.
Brief Summary: The main objectives of this study are to preliminarily evaluate the effectiveness of CG2001 in treating Chinese adult male AGA participants, determine the recommended dose for Phase III clinical studies, and evaluate the safety of CG2001 at the target dose.
Study Start Date: Dec. 05, 2024
Study Type: INTERVENTIONAL
Condition:
Male Pattern of Hair Loss, Androgenic Alopecia
Androgenetic Alopecia (AGA)
Intervention:
DRUG: minoxidil + finasteride
topical foam: 5%minoxidil+0.075%finasteride
DRUG: minoxidil +...